Coty (COTY) Q3 2026 Earnings Transcript

Coty said Prestige sell-in lagged sellout due to Middle East disruption, heavy promotions, and retailer destocking, while Consumer Beauty is shifting to smaller, more targeted bundles and exiting weaker markets. Management quantified tariff costs at about $30 million this year and said a $1 oil price move hits profit by roughly $2 million, with hedging expected to limit oil inflation through calendar 2026. The company is exiting Orveda by fiscal year-end and expects margin improvement to come gradually as SKU rationalization and sellout-focused execution take hold.

Analysis

The core issue is not demand destruction; it’s revenue recognition timing. Coty is deliberately pulling back sell-in to repair retailer economics, which should improve returns and inventory quality but mechanically suppresses reported growth for several quarters. That creates a classic “looks worse before it looks better” setup: gross margin and EBITDA remain noisy near-term, but working capital and cash conversion can inflect earlier than the P&L if the bundle rationalization sticks.

The more important second-order effect is competitive. By narrowing assortment and pushing higher-ROI media, Coty is effectively conceding low-productivity shelf space to peers in exchange for stronger retail productivity on a smaller base. That usually benefits the best-capitalized mass beauty players with sharper execution and hurts weaker incumbents that rely on promo-driven share defense. If the company’s Gen X positioning and streamlined launches really work, the surprise will be in unit share, not revenue growth, and that is where the market is underweighting the upside.

The medium-term overhang is external inflation rather than internal strategy. Oil, freight, glass, plastics, and tariffs create a layered cost stack that can delay margin recovery even if sellout improves, while Middle East disruption is a channel-specific shock that can persist in travel retail longer than headline geopolitics suggests. The key catalyst is not a clean macro normalization; it is evidence over the next 1-3 quarters that fewer launches are generating higher sellout with lower returns, which would validate the new operating model and narrow the gap to category growth.

Contrarian view: the market may be extrapolating too much downside from the sell-in miss and too little from cash discipline. If management can hold A&CP flat while shifting spend toward the highest-ROI periods, then EBITDA can stabilize before top-line optics do. The risk is execution fatigue: if the next two bundle cycles do not materially reduce obsolescence, investors will conclude the restructuring is incremental rather than transformative.

Key Decisions for Investors

• Long COTY on a 3-6 month horizon only on pullbacks: thesis is working-capital and cash-flow inflection before reported revenue recovery; downside risk is continued sell-in underperformance if promotions stay elevated.
• Buy COTY Jan-2027 call spreads to express a delayed operating-model reset; risk/reward favors defined-risk upside because the market can re-rate on proof of lower returns and improving EBITDA trajectory.
• Pair trade: long COTY / short a higher-inventory beauty peer with more promo exposure over the next 2 quarters; Coty’s tighter SKU discipline should outperform once the market rewards cash conversion over reported growth.
• Avoid chasing the move in the next 4-8 weeks: the near-term setup still contains Middle East and tariff noise, so a better entry is after the next bundle cycle or any guide-down tied to temporary inventory effects.
• Monitor for a tactical short if obsolescence/returns fail to decline by the next earnings call; if that happens, the restructuring narrative loses credibility and multiple compression is likely.